Measurement of exhaled nitric oxide concentrations in asthma. Technical aspects and clinical usefulness;Determinación de las concentraciones de óxido nítrico exhalado en el asma. Aspectos técnicos y utilidad clínica

Alergologia e Inmunologia Clinica

Volumn 17, Issue 2, 2002, Pages 72-87

  Prieto, L ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HISTAMINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; MONTELUKAST; NITRIC OXIDE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; ZAFIRLUKAST;

ANALYTIC METHOD; ASTHMA; BREATH ANALYSIS; BRONCHITIS; BRONCHUS HYPERREACTIVITY; CLINICAL FEATURE; DRUG EFFECT; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; PATIENT MONITORING; PATIENT SELECTION; PROVOCATION TEST; RESPIRATORY TRACT DISEASE; REVIEW; STEROID THERAPY;

EID: 0036080190     PISSN: 1575734X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (175)

1. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans
2. Increased carbon monoxide in exhaled air of asthmatic patients
3. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: A new marker for oxidative stress
4. The hydrocarbon breath test in the study of lipid peroxidation: Principles and practice
5. A system for the quantitative determination of hydrocarbons in human breath
6. Increased content of hydrogen peroxide in the expired breath of cigarette smokers
7. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma
8. Induction of nitric oxide synthase in asthma
9. NO waiting to exhale in asthma
10. Increased vascular expression of iNOS at day but not at night in asthmatic subjects with increased nocturnal airway obstruction
11. Endogenous nitric oxide in allergic airway disease
12. Rhinovirus infection induces expression of type 2 nitric oxide synthase in human respiratory epithelial cells in vitro and in vivo
13. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus
14. Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment
15. Effect of nebulised L-arginine on exhaled nitric oxide in steroid naive asthma
16. Molecular mechanisms of increased nitric oxide (NO) in asthma: Evidence for transcriptional and post-translational regulation of NO synthesis
17. Role of transcription factor NF-kB/rel in induction of nitric oxide synthase
18. Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice
19. Endogenous airway acidification: Implications for asthma pathophysiology
20. Modelling the production of nitric oxide within the human airways
21. The current single exhalation method of measuring exhaled nitric oxide is affected by airway calibre
22. Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma
23. Exhaled and nasal nitric oxide measurements: Recommendations
24. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999
25. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide
26. Flow-dependency of exhaled nitric oxide in children with asthma and cystic fibrosis
27. Nasal contribution to exhaled nitric oxide at rest and during breath-holding in humans
28. High nitric oxide production in human paranasal sinuses
29. Origins of breath nitric oxide in humans
30. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract
31. Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding
32. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects
33. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response
34. Influence of environmental concentrations of NO on the exhaled NO test
35. Exhaled nitric oxide levels correlate with measures of disease control in asthma
36. Measurement of exhaled nitric oxide by three different techniques
37. Air contamination with nitric oxide. Effect on exhaled nitric oxide response
38. Influence of atmospheric nitric oxide concentration on the measurement of nitric oxide in exhaled air
39. Airway nitric oxide in asthmatic children and patients with cystic fibrosis
40. Off-line sampling of exhaled air for nitric oxide measurement in children: Methodological aspects
41. Increased nitric oxide in exhaled air of asthmatic patients
42. Single-breath nitric oxide measurements in asthmatic patients and smokers
43. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections
44. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients
45. The effect of alcohol ingestion on exhaled nitric oxide
46. Effect of short-and long-acting inhaled α2-agonists on exhaled nitric oxide in asthmatic patients
47. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide
48. Sampling of exhaled nitric oxide in children: End-expiratory plateau, balloon and tidal breathing methods compared
49. A simple flow-driven method for on line measurement of exhaled NO starting at the age of 4 to 5 years
50. Controlled low flow off line sampling of exhaled nitric oxide in children
51. A new method for the remote collection of nasal and exhaled nitric oxide
52. Nitric oxide measured with single-breath and tidal-breathing methods in asthma and COPD
53. A method for the standardized offline collection of exhaled nitric oxide
54. Reference values of exhaled nitric oxide for healthy children 6-15 years old
55. Childhood asthma: Exhaled nitric oxide in relation to clinical symptoms
56. Reproducibility of measurements of exhaled NO, and cell count and cytokine concentrations in induced sputum
57. L-arginine increases exhaled nitric oxide in normal human subjects
58. Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects
59. Effect of enalapril on exhaled nitric oxide in normotensive and hypertensive subjects
60. Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans
61. Increased nitric oxide in exhaled air after intake of a nitrate-rich meal
62. Raised exhaled nitric oxide in healthy children is associated with domestic formaldehyde levels
63. Respiratory nitric oxide levels in experimental human influenza
64. Effects of nitrogen dioxide exposure and ascorbic acid supplementation on exhaled nitric oxide in healthy humans subjects
65. Exhaled NO following repeated spirometry or repeated plethysmography in healthy individuals
66. Exhaled nitric oxide after beta2-agonist inhalation and spirometry in asthma
67. Exhaled nitric oxide during exercise: Site of release and modulation by ventilation and blood flow
68. Peak expiratory nitric oxide differences in men and women: Relation to the menstrual cycle
69. Effects of immersion in cool water on lung-exhaled nitric oxide at rest and during exercise
70. Acute and chronic effects of cigarette smoking on exhaled nitric oxide
71. Passive smoke inhalation decreases exhaled nitric oxide in normal subjects
72. Ethanol can inhibit nitric oxide production
73. Exhaled nitric oxide among pulpmill workers reporting gassing incidents involving ozone and chlorine dioxide
74. Effect of inhaled ozone on exhaled nitric-oxide, pulmonary function, and induced sputum in normal and asthmatic subjects
75. Increased amount of nitric oxide in exhaled air of asthmatics
76. Increased nitric oxide in exhaled air of asthmatic patients
77. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis
78. Exhaled and nasal NO levels in allergic rhinitis: Relation to sensitization, pollen season and bronchial hyperresponsiveness
79. Elevated levels of exhaled nitric oxide in bronchiectasis
80. Exhaled nitric oxide as a noninvasive assessment of chronic cough
81. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase
82. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype
83. Exhaled nitric oxide is reduced in infants with cystic fibrosis
84. Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease
85. Decreased nitric oxide in the exhaled air of systemic sclerosis patients with pulmonary hypertension
86. Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia
87. Exhaled nitric oxide is increased in active fibrosing alveolitis
88. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension
89. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages
90. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer
91. Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndrome
92. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease
93. Exhaled nitric oxide in chronic obstructive pulmonary disease
94. Exhaled nitric oxide in chronic obstructive pulmonary disease: Relationship to pulmonary function
95. Exhaled carbon monoxide and nitric oxide in COPD
96. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease
97. Increased exhaled nitric oxide in chronic bronchitis. Comparison with asthma and COPD
98. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease
99. Endogenous nitric oxide in patients with stable COPD: Correlates with severity of disease
100. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in cronic obstructive pulmonary disease
101. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease
102. Las limitaciones del modelo funcional de respuesta a la provocación bronquial con alergenos en el asma
103. Exhaled nitric oxide: A new lung function test
104. Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma
105. Alterations in exhaled gas profile during allergen-induced asthmatic response
106. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma
107. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children
108. Allergen avoidance is associated with a fall in exhaled nitric oxide in asthmatic children
109. Exhaled nitric oxide, sensitization, and exposure to allergens in patients with asthma who are not taking inhaled steroids
110. Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children
111. Exhaled nitric oxide in asthmatic children exposed to relevant allergens: Effect of flunisolide
112. Exhaled NO reduced on allergen avoidance
113. Prostaglandins E2 and F2a reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes
114. Exhaled nitric oxide decreases during exercise-induced bronchoconstriction in children with asthma
115. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide
116. Atopy influences exhaled nitric oxide levels in adult asthmatics
117. Exhaled nitric oxide and its relationship to airway responsiveness and atopy in asthma
118. Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis
119. Sensitization and exposure to pet allergens in asthmatics versus non-asthmatics with allergic rhinitis
120. Exhaled nitric oxide in seasonal allergic rhinitis: Influence of pollen season and therapy
121. Exhaled nitric oxide and bronchial responsiveness to adenosine 5′-monophosphate in subjects with allergic rhinitis
122. Exhaled monoxides in asymptomatic atopic subjects
123. Increased nitric oxide production in the respiratory tract in asymptomatic Pacific Islanders: An association with skin prick reactivity to house dust mite
124. Peak flow variability and sputum eosinophilia in allergic rhinitis
125. Modifications of airway responsiveness to adenosine 5′-monophosphate and exhaled nitric oxide concentrations after the pollen season in subjects with pollen-induced rhinitis
126. (CCCTTT)n repeat polymorphism in the NOS2 gene promoter is associated with atopy
127. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
128. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma
129. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients
130. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma
131. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast
132. Expired nitric oxide levels during treatment of acute asthma
133. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation
134. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease. Effects of inhaled beclomethasone
135. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients
136. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast
137. Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma
138. Exhaled nitric oxide during acute changes of airways calibre in asthma
139. Exhaled nitric oxide after b2-agonist inhalation and spirometry in asthma
140. Interleukin-4 receptor in moderate atopic asthma. A phase III randomized, placebo-controlled trial
141. Exhaled nitric oxide (ENO) and anti-inflammatory effects of a recombinant humanized monoclonal antibody to IgE (RHUMAB-E25) in pediatric asthma
142. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids
143. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma
144. Airway inflammation, exhaled nitric oxide, and severity of asthma in patients with western red cedar asthma
145. Exhaled nitric oxide: Relationship to clinico-physiological markers of asthma severity
146. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma
147. Expired nitric oxide and airway obstruction in asthma patients with an acute exacerbation
148. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma
149. Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild intermittent asthma
150. Baseline airway hyperresponsiveness and its reversible component: Role of airway inflammation and airway calibre
151. Exhaled nitric oxide, serum ECP and airway responsiveness in mild asthmatic children
152. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma
153. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation
154. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects
155. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma
156. The effect of cigarette smoking on exhaled nitric oxide in mild steroid-naive asthmatics
157. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness
158. Exhaled nitric oxide and exercise-induced bronchoconstriction in asthmatic children
159. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma
160. 20 of methacholine
161. Effect of salmeterol on seasonal changes in airway responsiveness and exhaled nitric oxide in pollen-sensitive asthmatic subjects
162. Relationship between exhaled nitric oxide and childhood asthma
163. Exhaled nitric oxide. Is it really a good marker of airway inflammation?
164. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone
165. Airway inflammation is present during clinical remission of atopic asthma
166. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
167. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry
168. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: Results of a factor analysis
169. Sputum in severe exacerbations of asthma. Kinetics of inflammatory indices after prednisone treatment
170. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time
171. Changes in sputum eosinophils predict loss of asthma control
172. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids
173. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control
174. Does exhaled nitric oxide reflect asthma control? Yes, it does!